Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 8957820, 8 pages
http://dx.doi.org/10.1155/2016/8957820
Research Article

Qualitative/Chemical Analyses of Ankaferd Hemostat and Its Antioxidant Content in Synthetic Gastric Fluids

1National Food Reference Laboratory, Department of Mineral Analyses, Ministry of Food Agriculture and Livestock, 06170 Ankara, Turkey
2Department of Pediatric Hematology, TOBB-ETU Hospital, 06570 Ankara, Turkey
3Department of Adult Hematology, Hacettepe University Medical School, 06100 Ankara, Turkey

Received 30 November 2015; Revised 29 December 2015; Accepted 6 January 2016

Academic Editor: Gail B. Mahady

Copyright © 2016 Ahmet Koluman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Z. Haznedaroglu, Y. Beyazit, S. L. Walker, and I. C. Haznedaroglu, “Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostat,” Critical Reviews in Oncology/Hematology, vol. 83, no. 1, pp. 21–34, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Ozel-Demiralp, N. Igci, B. Ayhan, Y. Egin, I. C. Haznedaroglu, and N. Akar, “Prohemostatic and antithrombin activities of ankaferd hemostat are linked to fibrinogen gamma chain and prothrombin by functional proteomic analyses,” Clinical and Applied Thrombosis/Hemostasis, vol. 18, no. 6, pp. 604–610, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Beyazit, M. Kurt, M. Kekilli, H. Goker, and I. C. Haznedaroglu, “Evaluation of hemostatic effects of Ankaferd as an alternative medicine,” Alternative Medicine Review, vol. 15, no. 4, pp. 329–336, 2010. View at Google Scholar · View at Scopus
  4. C. Akalin, S. Kuru, A. M. Barlas et al., “Beneficial effects of Ankaferd Blood Stopper on dermal wound healing: an experimental study,” International Wound Journal, vol. 11, no. 1, pp. 64–68, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Y. Gül Satar, I. T. Cangül, A. Topal, A. Oktay, K. Inan, and M. B. Akgül, “Effects of Ankaferd Blood Stopper (ABS) and topical tripeptide copper complex (TCC) on wound healing in Rats: an experimental study,” Kafkas Universitesi Veteriner Fakultesi Dergisi, vol. 20, no. 4, pp. 545–551, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Kaya, M. T. Gokdemir, O. Sogut, T. Demir, and S. Koçarslan, “Effects of folk medicinal plant extract ankaferd blood stopper on burn wound healing,” Acta Medica Mediterranea, vol. 29, no. 3, pp. 497–502, 2013. View at Google Scholar · View at Scopus
  7. T. Korkmaz, N. G. Sarikas, A. Kilicgun, E. Serin, and C. Boran, “The mechanism of activity of ankaferd blood stopper in the control of arterial bleeding and in the process of wound healing,” HealthMED, vol. 6, no. 11, pp. 3736–3743, 2012. View at Google Scholar · View at Scopus
  8. S. Yüce, C. Çandirli, S. Yenidünya, and B. Muslu, “New hemostatic agent: the effect of ankaferd blood stopper on healing wounds in experimental skin incision model,” Turkish Journal of Medical Sciences, vol. 44, no. 2, pp. 288–294, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. D. O. Demiralp, I. C. Haznedaroglu, and N. Akar, “Functional proteomic analysis of Ankaferd (R) Blood Stopper,” Turkish Journal of Hematology, vol. 27, no. 2, pp. 70–77, 2010. View at Google Scholar
  10. E. Yilmaz, S. Gulec, D. Torun, I. C. Haznedaroglu, and N. Akar, “The effects of Ankaferd (R) Blood Stopper on transcription factors in HUVEC and the erythrocyte protein profile,” Turkish Journal of Hematology, vol. 28, no. 4, pp. 276–285, 2011. View at Publisher · View at Google Scholar
  11. H. O. Kazancıoğlu, O. Çakir, G. Ak, and B. Zülfikar, “The effectiveness of a new hemostatic agent (Ankaferd blood stopper) for the control of bleeding following tooth extraction in hemophilia: a controlled clinical trial,” Turkish Journal of Hematology, vol. 30, no. 1, pp. 19–24, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. A. M. Teker, A. Y. Korkut, O. Gedikli, and V. Kahya, “Prospective, controlled clinical trial of Ankaferd Blood Stopper in children undergoing tonsillectomy,” International Journal of Pediatric Otorhinolaryngology, vol. 73, no. 12, pp. 1742–1745, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. A. M. Teker, A. Y. Korkut, V. Kahya, and O. Gedikli, “Prospective, randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis,” European Archives of Oto-Rhino-Laryngology, vol. 267, no. 9, pp. 1377–1381, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Z. Amer, S. I. Mourad, A. S. Salem, and E. Abdelfadil, “Correlation between international normalized ratio values and sufficiency of two different local hemostatic measures in anticoagulated patients,” European Journal of Dentistry, vol. 8, no. 4, pp. 475–480, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. O. S. Balcik, M. Koroglu, H. Cipil et al., “A placebo-controlled, randomized, double-blinded, cross-over phase-I clinical study indicating the safety of topical ankaferd hemostat in healthy volunteers,” UHOD: Uluslararasi Hematoloji-Onkoloji Dergisi, vol. 22, no. 4, pp. 267–274, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Guler, G. Maralcan, S. Kul, I. Baskonus, and M. Yilmaz, “The efficacy of ankaferd blood stopper for the management of bleeding following total thyroidectomy,” Journal of Investigative Surgery, vol. 24, no. 5, pp. 205–210, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. E. Odabaş, C. Çinar, Ö. Tulunoglu, and B. Işik, “A new Haemostatic agent's effect on the success of calcium hydroxide pulpotomy in primary molars,” Pediatric Dentistry, vol. 33, no. 7, pp. 529–534, 2011. View at Google Scholar · View at Scopus
  18. H. Yasar and H. Ozkul, “Haemostatic effect of ankaferd blood stopper (R) seen during adenoidectomy,” African Journal of Traditional Complementary and Alternative Medicines, vol. 8, no. 4, pp. 444–446, 2011. View at Google Scholar
  19. T. Patiroglu, N. G. Sahin, and E. Unal, “Efficacy of Ankaferd Blood Stopper in prophylaxis and treatment of oral mucositis in pediatric malignancies: a pilot study,” in Proceedings of the World Federation of HemophiliaWorld Congress (WFH '14), Melbourne, Australia, May 2014. View at Publisher · View at Google Scholar
  20. F. Avcu, M. Guner, M. Misirci et al., “Evaluation of anti-neoplastic effects of a new hemostatic agent ankaferd blood stopper on myeloma cell line and plasmocytoma development in Balb/c mice: results of the first in vitro and in vivo study,” Blood, vol. 124, no. 21, article 5728, 2014. View at Google Scholar
  21. M. Mumcuoglu, D. F. Akin, U. Ezer, and N. Akar, “Ankaferd Blood Stopper induces apoptosis and regulates PAR1 and EPCR expression in human leukemia cells,” Egyptian Journal of Medical Human Genetics, vol. 16, no. 1, pp. 19–27, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Akalin, F. V. Okur, I. C. Haznedaroglu, N. Sayinalp, S. Aksu, and Y. Buyukasik, “Acute in vitro effects of ABS (Ankaferd Hemostat) on the lymphoid neoplastic cells (B-CLL and RAJI tumor cell lines),” Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi, vol. 24, pp. 253–259, 2014. View at Google Scholar
  23. A. Deveci, A. Y. Çoban, Y. Tanriverdi Çayci et al., “In Vitro effect of ankaferd blood stopper®, a plant extract against mycobacterium tuberculosis Isolates,” Mikrobiyoloji Bulteni, vol. 47, no. 1, pp. 71–78, 2013. View at Google Scholar · View at Scopus
  24. Y. Beyazit, M. Kekilli, I. C. Haznedaroglu, E. Kayacetin, and M. Basaranoglu, “Ankaferd hemostat in the management of gastrointestinal hemorrhages,” World Journal of Gastroenterology, vol. 17, no. 35, pp. 3962–3970, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Kurt, M. Akdogan, I. K. Onal et al., “Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: a retrospective analysis,” Digestive and Liver Disease, vol. 42, no. 3, pp. 196–199, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Kurt, E. Oztas, S. Kuran, I. K. Onal, M. Kekilli, and I. C. Haznedaroglu, “Tandem oral, rectal, and nasal administrations of Ankaferd Blood Stopper to control profuse bleeding leading to hemodynamic instability,” American Journal of Emergency Medicine, vol. 27, no. 5, pp. 631.e1–631.e2, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Karaman, M. Baskol, S. Gursoy et al., “Endoscopic topical application of ankaferd blood stopper® in gastrointestinal bleeding,” Journal of Alternative and Complementary Medicine, vol. 18, no. 1, pp. 65–68, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Akkoç, M. Akçelik, I. C. Haznedaroğlu et al., “In vitro anti-bacterial activities of ankaferd medicinal plant extract,” Turkiye Klinikleri Tip Bilimleri Dergisi, vol. 29, no. 2, pp. 410–415, 2009. View at Google Scholar
  29. Z. Saribas, B. Sener, I. C. Haznedaroglu, G. Hascelik, S. Kirazli, and H. Goker, “Antimicrobial activity of Ankaferd Blood Stopper® against nosocomial bacterial pathogens,” Central European Journal of Medicine, vol. 5, no. 2, pp. 198–202, 2010. View at Google Scholar
  30. N. T. Fisgin, Y. T. Cayci, A. Y. Coban et al., “Antimicrobial activity of plant extract Ankaferd Blood Stopper®,” Fitoterapia, vol. 80, no. 1, pp. 48–50, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Ciftci, F. Keskin, S. K. Ozcan et al., “In vitro antifungal activity of Ankaferd Blood Stopper against Candida albicans,” Current Therapeutic Research—Clinical and Experimental, vol. 72, no. 3, pp. 120–126, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Hasgul, S. Uysal, H. Haltas et al., “Protective effects of Ankaferd blood stopper on aspirin-induced oxidative mucosal damage in a rat model of gastric injury,” Toxicology and Industrial Health, vol. 30, no. 10, pp. 888–895, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. I. C. Haznedaroglu, “Molecular basis of the pleiotropic effects of ankaferd blood stopper,” IUBMB Life, vol. 61, no. 3, article 290, 2009. View at Google Scholar
  34. K. Molly, M. V. Woestyne, I. DeSmet, and W. Verstraete, “Validation of the simulator of the human intestinal microbial ecosystem (SHIME) reactor using microorganism-associated activities,” Microbial Ecology in Health and Disease, vol. 7, no. 4, pp. 191–200, 1994. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Xiao, Y. Shao, W. Yan, and Z. Zhang, “Measurement and correlation of solubilities of apigenin and apigenin 7-O-rhamnosylglucoside in seven solvents at different temperatures,” The Journal of Chemical Thermodynamics, vol. 43, no. 3, pp. 240–243, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. A. A. Albahrani, V. Rotarou, P. J. Roche, and R. F. Greaves, “Comparison of three commercial calibrators for alpha-tocopherol using liquid chromatography-tandem mass spectrometry,” Clinical Biochemistry, vol. 46, no. 18, pp. 1884–1888, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Gunay and R. Amanvermez, “The effect of Ankaferd on bone fracture healing,” Clinical Chemistry and Laboratory Medicine, vol. 49, p. S828, 2011. View at Google Scholar
  38. B. Z. Haznedaroglu, I. C. Haznedaroglu, S. L. Walker et al., “Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd blood stopper,” Clinical and Applied Thrombosis/Hemostasis, vol. 16, no. 4, pp. 446–453, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Akarsu, M. U. Kalayci, E. Yavuz et al., “Comparison of the hemostatic efficiency of Ankaferd Blood Stopper and fibrin glue on a liver laceration model in rats,” Turkish Journal of Trauma & Emergency Surgery, vol. 17, no. 4, pp. 308–312, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Akbal, S. Köklü, G. Karaca et al., “Beneficial effects of ankaferd blood stopper on caustic esophageal injuries,” Diseases of the Esophagus, vol. 25, no. 3, pp. 188–194, 2011. View at Publisher · View at Google Scholar
  41. E. Akbal, S. Köklü, G. Karaca et al., “Beneficial effects of Ankaferd Blood Stopper on caustic esophageal injuries: an experimental model,” Diseases of the Esophagus, vol. 25, no. 3, pp. 188–194, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Aktaş, N. Er, and P. Korkusuz, “Ankaferd-induced early wound healing of soft tissue in an experimental rat model,” Turkiye Klinikleri Tıp Bilimleri Dergisi, vol. 31, pp. 185–195, 2012. View at Google Scholar
  43. A. Alpay, S. Bektas, A. Alpay, S. C. Ugurbas, C. Evren, and S. H. Ugurbas, “Effects of a new hemostatic agent Ankaferd Blood Stopper® on the intraocular tissues in rat model,” Cutaneous and Ocular Toxicology, vol. 31, no. 2, pp. 128–131, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Alpay, S. C. Ugurbas, C. Evren, S. Bektas, S. Çaliskan, and S. H. Ugurbas, “Use of a novel haemostatic agent: ankaferd blood stopper in conjunctival incisions,” Clinical and Experimental Ophthalmology, vol. 39, no. 8, pp. 793–798, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Arslan, I. C. Haznedaroglu, B. Öz, and H. Goker, “Endobronchial application of Ankaferd blood stopper to control profuse lung bleeding leading to hypoxemia and hemodynamic instability,” Respiratory Medicine CME, vol. 2, no. 3, pp. 144–146, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Beyazit, S. Köklü, E. Akbal, M. Kurt, M. Kekilli, and I. C. Haznedaroglu, “Successful treatment of endoscopic sphincterotomyinduced early hemorrhage with application of Ankaferd Blood Stopper,” Gastrointestinal Endoscopy, vol. 72, no. 6, pp. 1325–1326, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. E. Eren, M. S. Başoğlu, E. Kulduk, F. Şimsek, and S. Inan, “Mucosal trauma induced apoptosis in guinea pig middle ear: comparision of hemostatic agents,” International Journal of Pediatric Otorhinolaryngology, vol. 78, no. 12, pp. 2222–2228, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Beyazit, E. Huri, T. Purnak, M. O. Guler, and I. C. Haznedaroglu, “Next generation nanomedicine in the genesis of ‘Ankaferd blood stopper nanohemostat’: a novel chimeric topical hemostatic agent for clinical hemorrhages,” Clinical and Applied Thrombosis-Hemostasis, vol. 20, no. 4, pp. 456–457, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. E. Huri, Y. Beyazit, R. Mammadov et al., “Generation of chimeric ‘ABS nanohemostat’ complex and comparing its histomorphological In vivo effects to the traditional Ankaferd hemostat in controlled experimental partial nephrectomy model,” International Journal of Biomaterials, vol. 2013, Article ID 949460, 10 pages, 2013. View at Publisher · View at Google Scholar
  50. V. Şen, Ü. Uluca, A. Ece et al., “Role of Ankaferd on bacterial translocation and inflammatory response in an experimental rat model of intestinal obstruction,” International Journal of Clinical and Experimental Medicine, vol. 7, no. 9, pp. 2677–2686, 2014. View at Google Scholar · View at Scopus
  51. A. Taş, S. Köklü, Y. Beyazit et al., “Percutaneous ankaferd injection to in vivo liver tissue in comparison to ethanol in an experimental rat model,” Clinics and Research in Hepatology and Gastroenterology, vol. 35, no. 8-9, pp. 549–553, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. N. Turhan, M. Kurt, A. Shorbagi, M. Akdogan, and I. C. Haznedaroglu, “Topical ankaferd blood stopper administration to bleeding gastrointestinal carcinomas decreases tumor vascularization,” The American Journal of Gastroenterology, vol. 104, no. 11, pp. 2874–2877, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. E. Akbal, S. Köklü, H. M. Astarci et al., “Oral high-dose ankaferd administration effects on gastrointestinal system,” International Journal of Medical Sciences, vol. 10, no. 4, pp. 451–456, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Aktas, N. Er, and M. A. Onur, “Effects of ankaferd blood stopper on vascular response in rat carotid artery,” Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi, vol. 20, no. 3, pp. 156–162, 2010. View at Google Scholar
  55. A. Durhan, S. Tuncal, K. Kismet et al., “Evaluation of intraabdominal adhesion generating potentials of ankaferd and calcium alginate used as hemostatic agents,” Bratislava Medical Journal, vol. 115, no. 9, pp. 544–549, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. K. Karaman, B. Celep, E. B. Bostanci et al., “Effects of ankaferd blood stopper on pancreatic fluid: an in vitro study,” ANZ Journal of Surgery, vol. 80, no. 12, pp. 946–947, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. E. Koçak, E. Akbal, A. Tas et al., “Anti-inflammatory efficiency of Ankaferd blood stopper in experimental distal colitis model,” Saudi Journal of Gastroenterology, vol. 19, no. 3, pp. 126–130, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. E. Yavuz, M. U. Kalayci, S. Kesici, U. Kesici, S. Ozkara, and O. Yalcin, “Efficacy of ankaferd blood stopper in bleeding control in experimental partial splenectomy model,” Kafkas Universitesi Veteriner Fakultesi Dergisi, vol. 18, no. 5, pp. 753–758, 2012. View at Google Scholar · View at Scopus
  59. V. Srinivasa, M. S. Sundaram, S. Anusha et al., “Novel apigenin based small molecule that targets snake venom metalloproteases,” PLoS ONE, vol. 9, no. 9, Article ID e106364, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Tasaki, T. Umemura, T. Inoue et al., “Induction of characteristic hepatocyte proliferative lesion with dietary exposure of Wistar Hannover rats to tocotrienol for 1 year,” Toxicology, vol. 250, no. 2-3, pp. 143–150, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Inoue, K. Takitani, M. Koh, C. Kawakami, T. Kuno, and H. Tamai, “Induction of apoptosis by γ-tocotrienol in human cancer cell lines and leukemic blasts from patients: dependency on bid, cytochrome c, and caspase pathway,” Nutrition and Cancer, vol. 63, no. 5, pp. 763–770, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. S. W. Lim, H. S. Loh, K. N. Ting, T. D. Bradshaw, and N. A. Zeenathul, “Cytotoxicity and apoptotic activities of alpha-, gamma- and delta-tocotrienol isomers on human cancer cells,” BMC Complementary and Alternative Medicine, vol. 14, article 469, 2014. View at Publisher · View at Google Scholar
  63. M. Sakai, M. Okabe, H. Tachibana, and K. Yamada, “Apoptosis induction by γ-tocotrienol in human hepatoma Hep3B cells,” Journal of Nutritional Biochemistry, vol. 17, no. 10, pp. 672–676, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Wada, Y. Satomi, M. Murakoshi, N. Noguchi, T. Yoshikawa, and H. Nishino, “Tumor suppressive effects of tocotrienol in vivo and in vitro,” Cancer Letters, vol. 229, no. 2, pp. 181–191, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. T. Miyazawa, A. Shibata, K. Nakagawa, and T. Tsuzuki, “Anti-angiogenic function of tocotrienol,” Asia Pacific Journal of Clinical Nutrition, vol. 17, supplement 1, pp. 253–256, 2008. View at Google Scholar · View at Scopus
  66. M. T. Ling, S. U. Luk, F. Al-Ejeh, and K. K. Khanna, “Tocotrienol as a potential anticancer agent,” Carcinogenesis, vol. 33, no. 2, pp. 233–239, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. E. Huri, T. Akgul, M. Astarci, H. Ustun, and C. Germiyanoglu, “The effect of a novel hemostatic agent, Ankaferd bloodstopper (R) (Abs), on renal tubular apoptosis in rat partial nephrectomy model,” Journal of Endourology, vol. 23, article A2, 2009. View at Google Scholar
  68. E. Huri, I. C. Haznedaroglu, T. Akgul, M. Astarci, H. Ustun, and C. Germiyanoulu, “Biphasic effects of ankaferd blood stopper on renal tubular apoptosis in the rat partial nephrectomy model representing distinct levels of hemorrhage,” Saudi Medical Journal, vol. 31, no. 8, pp. 864–868, 2010. View at Google Scholar · View at Scopus
  69. A. Mihmanli, Z. Ulker, L. Alpsoy, and S. Ezirganli, “Evaluation of cytotoxicity of a new hemostatic agent Ankaferd Blood Stopper® using different assays,” Human & Experimental Toxicology, vol. 31, no. 8, pp. 780–787, 2012. View at Publisher · View at Google Scholar · View at Scopus
  70. World Health Organization, “Guidelines for good clinical practice (GCP) for trials on pharmaceutical products,” WHO Technical Report Series 850, Annex 3, World Health Organization, 1995. View at Google Scholar